Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Neoplasms × Sitagliptin Phosphate × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 5 Diabetes Mellitus, Type 2 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Thyroid Nodule 1 Pancreatic Neoplasms 1 Neoplasms, Adipose Tissue 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Insulin Resistance 1 Infertility 1 Glioblastoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Body Weight 1

Interventions

Cyclophosphamide 322 Trastuzumab 306 Paclitaxel 272 Docetaxel 242 Capecitabine 208 Letrozole 196 Doxorubicin 165 Carboplatin 162 Tamoxifen 142 Radiotherapy 142 Fulvestrant 132 Epirubicin 125 Anastrozole 121 Surveys and Questionnaires 118 Exercise 111 Vinorelbine 104 palbociclib 96 exemestane 94 Blood Specimen Collection 94 Bevacizumab 93 Magnetic Resonance Spectroscopy 92 pertuzumab 88 pembrolizumab 88 Albumin-Bound Paclitaxel 79 Gemcitabine 76 Drug Therapy 70 Lapatinib 69 Cisplatin 63 Biopsy 63 130-nm albumin-bound paclitaxel 63

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07436663 2026-02-27

SGLT2i/DPPi

Tanta University

Phase 4 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡